Erika Siren, PhD
CEO,
Seragene Therapeutics
Canada
Erika Siren has been the CEO of Seragene Therapeutics since Oct 2023 and comes with 10+ years of experience spanning industry, entrepreneurship, and academia. With a specific interest in Rare Disease and Women’s Health, Erika looks forward to developing long-lasting RNA-based therapies for treating blood coagulation disorders using Seragene’s promising nanomedicine technology
Sessions
-
27-Feb-2024Seragene Therapeutics
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}